Community Outreach and Engagement

CCSG组件005 -社区外展和参与 项目概要/摘要 范德比尔特-英格拉姆癌症中心（VICC）位于癌症发病率最高的地区， 美国的死亡率。作为唯一一家NCI指定的综合癌症中心， 在田纳西州（TN）的儿科人群中，VICC涵盖了地理范围广，人口统计学上 横跨田纳西州、肯塔基州西部（KY）和北方亚拉巴马（AL）的123个县的多样化集水区， 目前90%的VICC癌症患者都是如此。123个县中有70个（57%）被列为 农村，25%的集水区人口居住在农村。VICC社区外联和参与（COE）， 在副主任Pamela船体博士（CO）的领导下，与VICC研究计划相结合 和行政措施，以减少癌症负担和差距内的集水区和超越。 COE以双向的方式，利用与患者和社区利益相关者的关系， 来自社区的研究，癌症控制和护理的优先事项，并与VICC研究计划合作 和社区合作伙伴，把这些优先倡议带到社区。COE的具体目标是 目的：1）评估并优先考虑集水区与癌症相关的需求和机会; 2）告知并促进 对已确定的癌症相关需求和社区驱动的优先事项作出反应的方案研究; 和3）促进循证癌症预防、控制和护理的实施和传播。 通过特遣队所属装备确定的社区驱动的优先事项包括癌症预防倡议、改善获得 通过技术、整体治疗和支持提供护理，实施循证实践和政策， 推进发现和研究宣传。VICC开展基础、临床和人口科学研究 满足集水区的需求，并与这些社区驱动的优先事项保持一致。COE工作人员协作 与合作伙伴一起，通过各种协作性社区外展活动，满足不断变化的社区确定的需求 活动与合作伙伴和利益攸关方合作，VICC社区知情研究和癌症 控制活动协同有助于增强健康和癌症识字社区在我们的 集水区及以外地区。这些努力的影响已经在范德比尔特的改进实践中显现出来 大学医学中心（VUMC）和附属网站，包括新提供的烟草筛查/咨询， 增强患者导航，扩大肺癌筛查范围，提高乳腺癌的依从性， 结直肠癌和宫颈癌筛查指南、HPV疫苗接种和遗传性癌症筛查。移动 今后，重点将放在增加应计研究的指标上;改善癌症- 相关知识、态度和行为;扩大实施循证指南， 卫生政策。与社区合作伙伴一起，维也纳国际中心通过促进 系统的方法来治疗癌症，推进基础研究，并将发现从实验室转化为 诊所，社区和人口在集水区，国家和全球。

CCSG COMPONENT 005 – COMMUNITY OUTREACH AND ENGAGEMENT PROJECT SUMMARY/ABSTRACT Vanderbilt-Ingram Cancer Center (VICC) is located in a region with some of the highest cancer incidence and mortality rates in the US. As the only NCI-designated Comprehensive Cancer Center serving both adult and pediatric populations in Tennessee (TN), VICC encompasses a geographically wide and demographically diverse catchment area of 123 counties across TN, western Kentucky (KY), and northern Alabama (AL) from which 90% of VICC cancer patients currently are drawn. Seventy of the 123 counties (57%) are classified as rural, in which 25% of the catchment area population lives. VICC Community Outreach and Engagement (COE), under the leadership of Associate Director Pamela Hull, PhD (CO), integrates with VICC Research Programs and administrative initiatives to reduce the cancer burden and disparities within the catchment area and beyond. In a bi-directional manner, leveraging relationships with patients and community stakeholders, COE obtains input from the community on priorities for research, cancer control and care and works with VICC research programs and community partners to bring those prioritized initiatives out to the community. The specific aims of COE are to: 1) Assess and prioritize cancer-related needs and opportunities in the catchment area; 2) Inform and facilitate programmatic research that is responsive to identified cancer-related needs and community-driven priorities; and 3) Promote the implementation and dissemination of evidence-based cancer prevention, control and care. Community-driven priorities identified through COE include cancer prevention initiatives, improved access to care through technology, holistic treatment and support, implementation of evidence-based practice and policy, advancing discoveries, and research advocacy. VICC conducts basic, clinical and population science research that addresses catchment area needs and aligns with these community-driven priorities. COE staff collaborate with partners to meet evolving community-identified needs through a variety of collaborative community outreach activities. Working together with partners and stakeholders, VICC community-informed research and cancer control activities synergistically contribute to empowering healthy and cancer literate communities in our catchment area and beyond. The impact of these efforts is already evident in improved practices at Vanderbilt University Medical Center (VUMC) and affiliated sites, including newly available tobacco screening/counseling, enhanced patient navigation, expanded reach of lung cancer screening and improved adherence to breast, colorectal and cervical cancer screening guidelines, HPV vaccination and inherited cancer screening. Moving forward, focus will be placed on metrics of increased accruals to research studies; improvements in cancer- related knowledge, attitudes and behavior; and expanded implementation of evidence-based guidelines and health policies. Together with community partners, VICC positively impacts the catchment area by enabling a systems approach to cancer, advancing fundamental research and translating discoveries from the bench to the clinic, community and population in the catchment area, nationally, and globally.